Russian version English version
Volume 9   Issue 2   Year 2014
Ivanisenko N.V., Gubanova N.V., Kolchanov N.A., Ivanisenko V.A.

Identification of Gene Markers for Aggressive Forms of Low-Grade Glioma Using TCGA Expression Data

Mathematical Biology & Bioinformatics. 2014;9(2):527-533.

doi: 10.17537/2014.9.527.


  1. Mittler M, Walters BC, Stopa EG. Observer reliability in histological grading of astrocytoma stereotactic biopsies. J. Neumsurg. 1996;85:1091-1094. doi: 10.3171/jns.1996.85.6.1091
  2. McLendon R, Friedman A, Bigner D, Van Meir EG, Brat DJ, Mastrogianakis GM, Olson JJ, Mikkelsen T, Lehman N, Yung WKA et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061-1068. doi: 10.1038/nature07385
  3. Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in biological networks. Bioinformatics. 2005;21:3448-3449. doi: 10.1093/bioinformatics/bti551
  4. Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431-432. doi: 10.1093/bioinformatics/btq675
  5. Ma Y, Ye F, Xie X, Zhou C, Lu W. Significance of PTPRZ1 and CIN85 expression in cervical carcinoma. Archives of gynecology and obstetrics. 2011;284:699-704. doi: 10.1007/s00404-010-1693-9
  6. Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line. Laboratory investigation. 2003;84:8-20. doi: 10.1038/labinvest.3700003
  7. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gu N, Koh C, Zhang J, Li YM, Maciaczyk J et al. NOTCH Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts. Stem cells. 2010;28(1):5-16.
  8. Fan Y, Potdar AA, Gong Y, Eswarappa SM, Donnola S, Lathi JD, Hambardzumyan D, Rich JN, Fox PL. Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation. Nature cell biology. 2014;16(5):445-456. doi: 10.1038/ncb2954
  9. Esposito I, Kayed H, Keleg S, Giese T, Sage EH, Schirmacher P, Friess H, Kleeff J. Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer. Neoplasia. 2007;9(1):8-17. doi: 10.1593/neo.06646
  10. Donninger H, Vos MD, Clark GJ. The RASSF1A tumor suppressor. Journal of cell science. 2007;120(18):3163-3172. doi: 10.1242/jcs.010389
  11. Taniguchi CM, Winnay J, Kondo T, Bronson RT, Guimaraes AR, Alemán JO, Luo J, Stephanopoulos G, Weissleder R, Cantley LC, Kahn CR. The phosphoinositide 3-kinase regulatory subunit p85α can exert tumor suppressor properties through negative regulation of growth factor signaling. Cancer research. 2010;70(13):5305-5315. doi: 10.1158/0008-5472.CAN-09-3399
  12. José-Enériz ES, Román-Gómez J, Cordeu L, Ballestar E, Gárate L, Andreu EJ, Isidro I, Guruceaga E, Jiménez-Velasco A, Heiniger A. BCR-ABL1-induced expression of HSPA8 promotes cell survival in chronic myeloid leukaemia. British journal of haematology. 2008;142(4):571-582.
  13. Demenkov PS, Ivanisenko TV, Kolchanov NA, Ivanisenko VA. ANDVisio: A new tool for graphic visualization and analysis of literature mined associative gene networks in the ANDSystem. In Silico Biology. 2012;11(3):149-161.
Table of Contents Original Article
Math. Biol. Bioinf.
doi: 10.17537/2014.9.527
published in Russian

Abstract (rus.)
Abstract (eng.)
Full text (rus., pdf)


  Copyright IMPB RAS © 2005-2022